1. EDP‐297: A novel, farnesoid X receptor agonist—Results of a phase I study in healthy subjects. Issue 2 (21st November 2022) Authors: Marotta, Christine; Ahmad, Alaa; Luo, Ed; Oosterhaven, Jart; van Marle, Sjoerd; Adda, Nathalie Journal: Clinical and translational science Issue: Volume 16:Issue 2(2023) Page Start: 338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗